Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.
- W. Zhang
- , Jan Stoehlmacher
- , David J. Park
- , Dongyun Yang
- , Erin Borchard
- , J. Gil
- , Denice D. Tsao-Wei
- , Jim Yun
- , Michael Gordon
- , Oliver A. Press
- , Katrin Rhodes
- , Susan Groshen
- , Heinz Josef Lenz
Research output: Contribution to journal › Article › peer-review
68
Scopus
citations